Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app ease the mental toll of type 1 diabetes?

NCT ID NCT06308549

Symptom relief Sponsor: Maartje de Wit Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests whether a self-help app called MyDiaMate can reduce diabetes distress in adults with type 1 diabetes. Researchers are enrolling 660 participants across the Netherlands, UK, Spain, and Germany. The app aims to support mental health alongside usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MyDiaMate self-help application (behavioural intervention)
What this could lead to
If it works, this could offer a simple, app-based way to ease the emotional burden of living with type 1 diabetes.
What could go wrong
This is a behavioural intervention, not a medical treatment, so benefits may be modest. The trial is ongoing and results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

625 people

The number who actually took part.

Started

Apr 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 18 years old at signing the informed consent form * Type 1 diabetes diagnosis at least 6 months ago * Having access to the internet and a smartphone/tablet/laptop'/computer for the entire time of study participation * Experiencing diabetes distress (checked during a phone call between research assistant and participant. The condition is met if the participant has an average score of ≥2 on the 2-item Diabetes Distress Scale (DDS-2), representing clinically meaningful diabetes distress) Exclusion Criteria: * Having been diagnosed with a psychiatric disorder in the past 6 months for which the person is under psychological/psychiatric treatment * Suicidality * Having started a treatment with psychotropic medication in the past 3 months * Illiteracy * Experience of cognitive problems that hamper using MyDiaMate or vision/auditory problems that are hindering in daily life * Prior use of MyDiaMate (only applicable to participants in the Netherlands)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes distress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes distress Type 1 diabetes

Contacts and locations

Locations

  • Amsterdam UMC

    Amsterdam, North Holland, 1081HV, Netherlands

  • Forschungsinstitut Diabetes-Akademie Bad Mergentheim

    Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

  • King's College London

    London, United Kingdom, WC2R 2LS, United Kingdom

  • Universidad de Málaga

    Málaga, Spain, 29071, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.